Clarifying the Tylenol Debate
In 2025, President Donald Trump sparked widespread controversy when he suggested that taking Tylenol (acetaminophen) during pregnancy could be linked to an increased risk of autism. His claims, which raised alarms among expectant mothers and healthcare professionals alike, quickly made waves across the media. However, despite the attention these statements garnered, numerous medical experts and professional organizations have refuted the assertion, stating that there is no credible evidence linking acetaminophen use during pregnancy to autism. New research continues to emphasize that acetaminophen remains the safest and most commonly used option for managing pain and fever during pregnancy. In this article, we will examine the ongoing debate, the scientific evidence, and the role of medical organizations in addressing public concerns about acetaminophen use during pregnancy.
Tylenol’s Safety During Pregnancy: The Current Consensus
Acetaminophen, commonly sold under the brand name Tylenol, is widely regarded as the safest over-the-counter medication for treating pain and fever during pregnancy. It is often recommended by doctors because of its well-established safety profile compared to other pain relievers such as ibuprofen or aspirin, both of which can pose serious risks to a developing fetus. These include complications such as miscarriage, birth defects, and premature birth. In contrast, acetaminophen has been thoroughly studied and is deemed safe when used at the appropriate dose for short periods.
Dr. Nathaniel DeNicola, an obstetrician-gynecologist (ob-gyn) from Newport Beach, California, notes that his office received a surge of inquiries after Trump’s statements, but the public’s concerns subsided quickly. “The scientific medical community was so prompt in its response, reassuring patients and reinforcing the safety of Tylenol during pregnancy,” said DeNicola, who contributed to the American College of Obstetricians and Gynecologists (ACOG) guidelines on acetaminophen use during pregnancy.
The Trump Administration’s Claims and the Backlash
In September 2025, the Trump administration released a statement citing studies suggesting a potential link between acetaminophen use during pregnancy and neurodevelopmental disorders in children, including autism and ADHD. The U.S. Food and Drug Administration (FDA) also issued a letter advising healthcare providers to consider minimizing acetaminophen use for routine low-grade fevers during pregnancy, especially in light of the accumulating evidence that suggested a possible association with neurological conditions.
One of the key studies referenced by the White House was a review of 46 previous studies, published in BMC Environmental Health. The study found an association between prolonged acetaminophen use during pregnancy and an increased incidence of neurodevelopmental disorders. Dr. Andrea Baccarelli, senior author of the paper, stated that the risk was more prominent when acetaminophen was used for four weeks or longer.
However, many experts, including Dr. Baccarelli himself, caution against making sweeping conclusions from this research. He acknowledged that while acetaminophen use during pregnancy is important for managing fever, which can be harmful to both the mother and fetus, further research is needed to fully understand the potential risks. As Baccarelli emphasized, the benefits of using acetaminophen to reduce fever must also be weighed against the potential risks of untreated fever, which can lead to birth defects and complications.
New Research: No Link Between Tylenol and Autism
Despite the concerns raised by the Trump administration’s claims, new research has provided reassurance to expectant mothers and healthcare professionals. A study published in The Lancet Obstetrics, Gynaecology & Women’s Health in January 2026 reviewed data from more than 300,000 pregnancies and analyzed 43 studies on the use of acetaminophen during pregnancy. The study, led by Dr. Asma Khalil, a consultant obstetrician and fetal medicine specialist at St. George’s Hospital in London, found no evidence that acetaminophen exposure during pregnancy increases the likelihood of autism, ADHD, or intellectual disabilities in children.
Dr. Khalil’s team conducted a meta-analysis of 17 studies, and their findings aligned with previous research that had failed to demonstrate a significant association between acetaminophen and neurodevelopmental disorders. This study adds to a growing body of literature that supports the safety of acetaminophen when used appropriately during pregnancy.
“The results of our study should provide reassurance to expectant mothers and their healthcare providers,” said Dr. Khalil. “Acetaminophen remains a safe and effective treatment for pain and fever during pregnancy, and there is no evidence to support the claim that it causes autism or other neurodevelopmental disorders in children.”
The Importance of Addressing Fever During Pregnancy
One of the critical points that medical experts continue to emphasize is the importance of treating fever during pregnancy. Untreated fever can pose serious risks to both the mother and the fetus, including an increased risk of miscarriage, birth defects, and neurodevelopmental disorders. Dr. Lynn Yee, a maternal-fetal medicine physician at Northwestern University Feinberg School of Medicine, stressed that there are no better alternatives to acetaminophen for reducing fever during pregnancy.
“Untreated fevers can have short- and long-term impacts on fetal neurodevelopment,” said Dr. Yee. “It’s really important to treat your fever because we know that untreated fever during pregnancy is unhealthy for both the mom and the baby.”
Acetaminophen is recommended as the go-to treatment for fever during pregnancy due to its safety profile, and its use is supported by major medical organizations such as the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM). Both organizations have reaffirmed that acetaminophen is the safest over-the-counter medication for pain and fever relief during pregnancy when used judiciously.
The Role of Medical Experts in Guiding Public Perception
In the wake of Trump’s claims, medical organizations in the U.S. and around the world have stepped up their efforts to reassure the public about the safety of acetaminophen. The ACOG, the SMFM, and other reputable institutions have emphasized the importance of consulting a healthcare provider when considering the use of any medication during pregnancy. These organizations have worked diligently to counter misinformation and provide accurate, science-based information to expectant mothers.
Dr. Yee expressed confidence that the medical community’s response to the Tylenol controversy helped clarify the issue for many patients. “I’ve seen a decrease in concerns about Tylenol, especially since our professional organizations have provided such clear and consistent messaging,” she said. “Doctors and trusted healthcare institutions have done a great job getting the right messages out there.”
Ensuring Safety and Trust in Public Health Messaging
As research continues to evolve, it is crucial for both the medical community and the public to rely on credible, science-based information when making health decisions. While the controversy surrounding Trump’s Tylenol claims may have caused temporary confusion, the consensus among healthcare experts remains that acetaminophen is safe for use during pregnancy when taken at the appropriate dosage and under the guidance of a healthcare provider. Moving forward, it is essential to maintain open communication between patients and doctors to ensure that expectant mothers have access to the best possible care and information.
